BSEOthersRegulatory31 Aug 2026
Genomic Valley Biotech Ltd
Intimation of approval of Extension of time for holding Annual General Meeting (AGM) of the company for the financial year ended on 31st March 2026, pursuant to regulation 30 of SEBI (Listing ....
Genomic Valley Biotech Ltd has received approval from the Registrar of Companies, Haryana to extend the time for holding its Annual General Meeting (AGM) for the financial year ended 31st March 2026 by 3 months, from 30th September 2026 to 31st December 2026.
BSECompany UpdateResults17 Aug 2026
Genomic Valley Biotech Ltd
Please find enclosed herewith unaudited financial results for the quarter ended on 30th June, 2026.
Genomic Valley Biotech Ltd has published unaudited financial results for the quarter ended on 30th June, 2026.
BSEResultResults14 Aug 2026
Genomic Valley Biotech Ltd
Unaudited financial results for Quarter ended on 30 June 2026.
Genomic Valley Biotech Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company's management has approved the results, which have been reviewed by the statutory auditor ANDROS & CO. The results are based on the recognition and measurement principles laid down in Indian Accounting Standard 34 (Ind AS 34) and have been prepared in accordance with the Listing Regulations.
BSEBoard MeetingResults14 Aug 2026
Genomic Valley Biotech Ltd
Considered and approved the standalone Un-audited financial results of the company for the quarter ended on 30th June 2026.
Genomic Valley Biotech Ltd has announced the approval of its standalone un-audited financial results for the quarter ended June 30, 2026, at its board meeting held on August 14, 2026.
BSEBoard MeetingResults6 Aug 2026
Genomic Valley Biotech Ltd
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve unaudited financial ....
Genomic Valley Biotech Ltd has scheduled a board meeting on August 14, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.